go back

Massachusetts rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $645,654 · 10th–90th $645,654–$645,6540%50%100%$645,654Professionalmedian $977,237 · 10th–90th $977,237–$977,2370%50%100%$977,237$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
AllWays Health Partners
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$645,654.23 / $645,654.23 / $645,654.23
AllWays Health Partners
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$977,237.22 / $977,237.22 / $977,237.22
Mass General Brigham
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$645,654.23 / $645,654.23 / $645,654.23
Mass General Brigham
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$977,237.22 / $977,237.22 / $977,237.22